Disc Medicine, Inc.
IRON
$77.44
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.14M | 23.62M | 20.75M | 17.36M | 15.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.08M | 69.52M | 66.12M | 67.70M | 61.41M |
| Operating Income | -65.08M | -69.52M | -66.12M | -67.70M | -61.41M |
| Income Before Tax | -59.46M | -63.45M | -60.44M | -62.22M | -55.20M |
| Income Tax Expenses | 69.00K | 51.00K | 88.00K | 102.00K | 52.00K |
| Earnings from Continuing Operations | -59.53M | -63.50M | -60.53M | -62.32M | -55.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.53M | -63.50M | -60.53M | -62.32M | -55.25M |
| EBIT | -65.08M | -69.52M | -66.12M | -67.70M | -61.41M |
| EBITDA | -64.99M | -69.44M | -66.03M | -67.61M | -61.33M |
| EPS Basic | -1.54 | -1.65 | -1.61 | -1.77 | -1.58 |
| Normalized Basic EPS | -0.96 | -1.03 | -0.99 | -1.11 | -0.98 |
| EPS Diluted | -1.54 | -1.65 | -1.61 | -1.77 | -1.58 |
| Normalized Diluted EPS | -0.96 | -1.03 | -0.99 | -1.11 | -0.98 |
| Average Basic Shares Outstanding | 38.69M | 38.49M | 37.63M | 35.18M | 35.02M |
| Average Diluted Shares Outstanding | 38.69M | 38.49M | 37.63M | 35.18M | 35.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |